Primacor / Milrinone: Overview

Modified on 2009/10/14 21:46 by admin
Manufactured by Sanofi-Synthelabo Inc., Primacor is commonly used for the short-term treatment of severe congestive heart failure in hospitalized patients. Affecting nearly 5 million Americans, heart failure occurs when blood is inefficiently pumped around the body. The symptoms of this condition include weakness, breathlessness and a blue discoloration of the skin. Primacor, also known as milrinone, helps to maintain the output of blood from the heart. Primacor increases the force by which heart muscles work and opens up blood vessels to allow blood to flow more freely. The drug was approved in 1987. Side effects include, but may not be limited to, light-headedness, dizziness, chest pain, and headaches. In March 2002, researchers revealed that Primacor may cause dangerously low blood pressure and abnormal heart rhythms. Several medical experts are now recommending that the drug be used only on patients who do not respond positively to other medications. Sanofi-Synthelabo has admitted Primacor may not be safe or effective when given longer than 48 hours. According to the company, long-term oral treatment with the drug has been associated with an increased risk of hospitalization and death. See your doctor if you have experienced an adverse reaction after taking Primacor. In addition, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

See Also

  1. Heart Failure Drugs: Overview
  2. Arrhythmia: Overview
  3. Balance Problems: Overview
  4. Headaches
  5. Low Blood Pressure (hypotension): Overview
  Name Size